Literature DB >> 6112565

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

P Imbach, S Barandun, V d'Apuzzo, C Baumgartner, A Hirt, A Morell, E Rossi, M Schöni, M Vest, H P Wagner.   

Abstract

Seven children with chronic or intermittent and six with acute idiopathic thrombocytopenic purpura (ITP) were treated with large intravenous doses of polyvalent, intact immunoglobulin (Ig). In all patients the platelet count rose sharply within 5 days, but the initial response and the subsequent course varied from patient to patient. Among children with chronic ITP the initial response was more marked in splenectomised than in non-splenectomised patients. Among those with acute ITP the two who remained Ig dependent had a smaller initial response than the four patients who required no maintenance treatment. During the 90-110 days of observation five of six patients with chronic ITP could be maintained with Ig alone. No untoward effects of Ig therapy were observed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112565     DOI: 10.1016/s0140-6736(81)92400-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  267 in total

Review 1.  [Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].

Authors:  A Böcher; F G Hagmann; H Kreiter
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 2.  Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins.

Authors:  L Rauova; J Rovensky; Y Shoenfeld
Journal:  Springer Semin Immunopathol       Date:  2001-12

3.  From black magic to science: understanding the rationale for the use of intravenous immunoglobulin to treat inflammatory myopathies.

Authors:  S Y Patel; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

4.  Intravenous immunoglobulin (IVIG) preparations induce apoptosis in TNF-alpha-stimulated endothelial cells via a mitochondria-dependent pathway.

Authors:  K Nakatani; S Takeshita; H Tsujimoto; I Sekine
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

5.  Aortic valve replacement in a patient with idiopathic thrombocytopenic purpura.

Authors:  T Kumamoto; S Higashi; T Sumida
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-04

Review 6.  Immunomodulatory action of intravenous immunoglobulin.

Authors:  W A C Sewell; S Jolles
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

7.  A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation.

Authors:  D Nachbaur; M Herold; B Eibl; H Glassl; H Schwaighofer; C Huber; A Gächter; M Pichl; D Niederwieser
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

8.  Long-term outcomes of laparoscopic versus open splenectomy for immune thrombocytopenia.

Authors:  Kazuhiro Tada; Masayuki Ohta; Kunihiro Saga; Hiroomi Takayama; Teijiro Hirashita; Yuichi Endo; Hiroki Uchida; Yukio Iwashita; Masafumi Inomata
Journal:  Surg Today       Date:  2017-07-19       Impact factor: 2.549

9.  High-dose intravenous therapy with immune globulin before delivery for idiopathic thrombocytopenic purpura.

Authors:  R J Adderley; P C Rogers; D Shaw; L D Wadsworth
Journal:  Can Med Assoc J       Date:  1984-04-01       Impact factor: 8.262

10.  High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.

Authors:  M Basta; M C Dalakas
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.